Kiltearn Partners LLP Acquires 590,000 Shares of Ambev S.A. $ABEV

Key Points

• Kiltearn Partners LLP increased its stake in Ambev by 5.6%, buying 590,000 shares to hold 11,045,700 shares (about $24.63M), making Ambev its 7th largest holding, while several other institutions (Canada Life, MFS, Marshall Wace, BofA, GMO) also materially boosted positions and institutional ownership sits around 8.13%.
• Ambev reported quarterly EPS of $0.05 (in line) and revenue of $4.50 billion (beat estimates), has a market cap of $46.17B and P/E of 16.28, and recently paid a special dividend of $0.049 per share amid mixed analyst views (consensus "Hold" with a $2.69 target, though some firms have upgraded to "Buy").

Kiltearn Partners LLP grew its holdings in shares of Ambev S.A. (NYSE:ABEV - Free Report) by 5.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,045,700 shares of the company's stock after buying an additional 590,000 shares during the period. Ambev accounts for about 4.9% of Kiltearn Partners LLP's holdings, making the stock its 7th largest holding. Kiltearn Partners LLP owned about 0.07% of Ambev worth $24,632,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. CANADA LIFE ASSURANCE Co raised its position in shares of Ambev by 74.8% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 13,409,316 shares of the company's stock worth $32,624,000 after acquiring an additional 5,740,155 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Ambev by 12.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 36,058,376 shares of the company's stock worth $80,410,000 after purchasing an additional 3,864,844 shares during the last quarter. Marshall Wace LLP boosted its holdings in Ambev by 192.7% in the second quarter. Marshall Wace LLP now owns 4,208,299 shares of the company's stock valued at $10,142,000 after purchasing an additional 2,770,698 shares in the last quarter. Bank of America Corp DE increased its stake in Ambev by 9.9% in the second quarter. Bank of America Corp DE now owns 27,505,192 shares of the company's stock valued at $66,288,000 after purchasing an additional 2,479,310 shares during the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC increased its stake in Ambev by 12,937.7% in the second quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 2,385,900 shares of the company's stock valued at $5,750,000 after purchasing an additional 2,367,600 shares during the last quarter. 8.13% of the stock is owned by institutional investors and hedge funds.

Ambev Trading Up 0.3%

ABEV opened at $2.93 on Monday. The firm has a market cap of $46.17 billion, a price-to-earnings ratio of 16.28, a price-to-earnings-growth ratio of 2.15 and a beta of 0.64. Ambev S.A. has a 52 week low of $2.10 and a 52 week high of $3.24. The business's 50 day moving average is $2.83 and its two-hundred day moving average is $2.51. The company has a quick ratio of 0.73, a current ratio of 0.96 and a debt-to-equity ratio of 0.03.

Ambev (NYSE:ABEV - Get Free Report) last announced its earnings results on Thursday, February 12th. The company reported $0.05 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.05. The business had revenue of $4.50 billion for the quarter, compared to analyst estimates of $4.28 billion. Ambev had a net margin of 17.75% and a return on equity of 16.41%. On average, research analysts predict that Ambev S.A. will post 0.18 EPS for the current year.

Ambev Dividend Announcement

The firm also recently declared a special dividend, which was paid on Friday, January 9th. Investors of record on Monday, December 22nd were paid a dividend of $0.049 per share. The ex-dividend date was Monday, December 22nd. This represents a yield of 1,465.0%. Ambev's dividend payout ratio is currently 183.33%.

Wall Street Analyst Weigh In

ABEV has been the topic of a number of research analyst reports. Barclays raised their price objective on shares of Ambev from $2.50 to $3.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 17th. Sanford C. Bernstein reaffirmed a "market perform" rating and issued a $2.88 target price on shares of Ambev in a research report on Wednesday, November 26th. Wall Street Zen upgraded shares of Ambev from a "hold" rating to a "buy" rating in a research note on Saturday, February 21st. Finally, Weiss Ratings raised shares of Ambev from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $2.69.

Ambev Profile

Ambev NYSE: ABEV is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company's core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.